Updated Risk Assessment of Cannabidiol in Foods Based on Benchmark Dose–Response Modeling
Abstract Cannabidiol (CBD), a non-psychotropic main component of the Cannabis plant, has been approved as a drug in the European…
risk assessment
Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
Abstract Cannabidiol (CBD)-containing products are widely marketed as over the counter products. Adverse effects reported in anecdotal consumer reports or…
Regulation of Synthetic Biology: Developments Under the Convention on Biological Diversity and Its Protocols
Abstract The primary international forum deliberating the regulation of “synthetic biology” is the Convention on Biological Diversity (CBD), along with…